Patents by Inventor Huixia ZHANG

Huixia ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF N-BENZYLBENZAMIDE-BASED COMPOUND AS HERBICIDE
    Publication number: 20220330549
    Abstract: An N-benzylbenzamide-based compound as shown below or its salt which may be used as a herbicide is provided. The N-benzylbenzamide-based compound or its salt serves as a pigment synthesis inhibitor for controlling weeds in field crop growing places or non-farming crop places. Furthermore, the compound may form an agricultural herbicide with an agriculturally accepted carrier. Still further, the compound also serves an agricultural herbicide in a manner of a mixed formulation with a further herbicidal active component, particularly atrazine. The N-benzylbenzamide-based compound or its salt has high herbicidal activity, and can be used to control weeds that are resistant to existing herbicides, which thereby exhibits a good synergistic effect when combined with a further herbicidal active component.
    Type: Application
    Filed: September 2, 2020
    Publication date: October 20, 2022
    Inventors: Zhiqin JI, Shaopeng WEI, Huixia ZHANG
  • CD2-associated protein (CD2AP) and its interactive proteins
    Patent number: 11002729
    Abstract: A method for down-regulating CD2AP expression in a subject comprises administering a CD2AP down-regulation composition to the subject, wherein the CD2AP down regulation composition is workable by way of siRNA/shRNA, CRISPR/Cas9, Talen or ZFNs; thereby the CD2AP expression in liver tissues of the subject is down-regulated.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: May 11, 2021
    Assignee: WUHAN INSTITUTE OF VIROLOGY, CHINESE ACADEMY OF SCIENCES
    Inventors: Chaoyang Li, Huixia Zhang
  • CD2-ASSOCIATED PROTEIN (CD2AP) AND ITS INTERACTIVE PROTEINS
    Publication number: 20190353642
    Abstract: A method for down-regulating CD2AP expression in a subject comprises administering a CD2AP down-regulation composition to the subject, wherein the CD2AP down regulation composition is workable by way of siRNA/shRNA, CRISPR/Cas9, Talen or ZFNs; thereby the CD2AP expression in liver tissues of the subject is down-regulated.
    Type: Application
    Filed: June 14, 2017
    Publication date: November 21, 2019
    Applicant: WUHAN INSTITUTE OF VIROLOGY, CHINESE ACADEMY OF SCIENCES
    Inventors: Chaoyang LI, Huixia ZHANG